Biomerica (BMRA) Other Non-Current Assets (2011 - 2026)
Biomerica recorded quarterly Other Non-Current Assets of $89000.0 in Q1 2026, down 1.11% quarter-over-quarter from $90000.0 in Q4 2025, and down 21.24% year-over-year from $113000.0 in Q1 2025.
Biomerica's Other Non-Current Assets history runs 16 years deep, the most recent figure standing at $89000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 21.24% year-over-year to $89000.0; the TTM figure through Feb 2026 stood at $89000.0 (down 21.24% YoY), while the FY2025 annual figure was $113000.0, down 44.33% from the prior year.
- Other Non-Current Assets came in at $89000.0 for Q1 2026 at Biomerica, down from $90000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $203000.0 in Q2 2024 to a low of $78598.0 in Q1 2023.
- A 5-year average of $114925.9 and a median of $96000.0 in 2022 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets plunged 64.92% in 2022 and surged 156.96% in 2024, its largest moves.
- Biomerica's Other Non-Current Assets stood at $79654.0 in 2022, then gained by 20.52% to $96000.0 in 2023, then jumped by 80.21% to $173000.0 in 2024, then plunged by 47.98% to $90000.0 in 2025, then declined by 1.11% to $89000.0 in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $89000.0, $90000.0, and $100000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 140.49 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 | 89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 89,000.00 |
| Nov 30, 2025 | 90,000.00 |
| Aug 31, 2025 | 100,000.00 |
| May 31, 2025 | 113,000.00 |
| Feb 28, 2025 | 113,000.00 |
| Nov 30, 2024 | 173,000.00 |
| Aug 31, 2024 | 203,000.00 |
| May 31, 2024 | 203,000.00 |
| Feb 29, 2024 | 104,000.00 |
| Nov 30, 2023 | 96,000.00 |
| Aug 31, 2023 | 96,000.00 |
| May 31, 2023 | 79,000.00 |
| Feb 28, 2023 | 78,598.00 |
| Nov 30, 2022 | 79,654.00 |
| Aug 31, 2022 | 93,509.00 |
| May 31, 2022 | 96,000.00 |
| Feb 28, 2022 | 146,980.00 |
| Nov 30, 2021 | 149,581.00 |
| Aug 31, 2021 | 266,582.00 |
| May 31, 2021 | 264,151.00 |
| Feb 28, 2021 | 282,857.00 |
| Nov 30, 2020 | 262,278.00 |
| Aug 31, 2020 | 444,631.00 |
| May 31, 2020 | 168,193.00 |
| Feb 29, 2020 | 127,521.00 |
| Nov 30, 2019 | 124,759.00 |
| Aug 31, 2019 | 128,644.00 |
| May 31, 2019 | 126,832.00 |
| Feb 28, 2019 | 122,141.00 |
| Nov 30, 2018 | 119,851.00 |
| Aug 31, 2018 | 116,534.00 |
| May 31, 2018 | 113,157.00 |
| Aug 31, 2017 | 58,341.00 |
| May 31, 2017 | 94,989.00 |
| Feb 28, 2017 | 64,838.00 |
| Nov 30, 2016 | 62,915.00 |
| Aug 31, 2016 | 58,695.00 |
| May 31, 2016 | 55,653.00 |
| Feb 29, 2016 | 68,286.00 |
| Nov 30, 2015 | 65,891.00 |
| Aug 31, 2015 | 60,956.00 |
| May 31, 2015 | 56,838.00 |
| Feb 28, 2015 | 51,085.00 |
| Nov 30, 2014 | 45,018.00 |
| Aug 31, 2014 | 43,498.00 |
| May 31, 2014 | 36,297.00 |
| Feb 28, 2014 | 71,388.00 |
| Nov 30, 2013 | 71,388.00 |
| Aug 31, 2013 | 71,388.00 |
| May 31, 2013 | 71,388.00 |
| Feb 28, 2013 | 81,328.00 |
| Nov 30, 2012 | 78,561.00 |
| Aug 31, 2012 | 78,561.00 |
| May 31, 2012 | 78,561.00 |
| Feb 29, 2012 | 53,548.00 |
| Nov 30, 2011 | 52,510.00 |
| Aug 31, 2011 | 50,079.00 |
| May 31, 2011 | 47,888.00 |